Background This study aimed to determine whether patients with post-traumatic stress disorder (PTSD) show difficulty in recruitment of the regions of the frontal and parietal cortex implicated in top-down attentional control in the presence and absence of emotional distracters. Method Unmedicated individuals with PTSD (n=14), and age-, IQ- and gender-matched individuals exposed to trauma (n=15) and healthy controls (n=19) were tested on the affective number Stroop task. In addition, blood oxygen level-dependent responses, as measured via functional magnetic resonance imaging, were recorded. Results Patients with PTSD showed disrupted recruitment of lateral regions of the superior and inferior frontal cortex as well as the parietal cortex in the presence of negative distracters. Trauma-comparison individuals showed indications of a heightened ability to recruit fronto-parietal regions implicated in top-down attentional control across distracter conditions. Conclusions These results are consistent with suggestions that emotional responsiveness can interfere with the recruitment of regions implicated in top-down attentional control ; the heightened emotional responding of patients with PTSD may lead to the heightened interference in the recruitment of these regions.
The recent development of low-risk imaging technologies, such as functional magnetic resonance imaging (fMRI), have had a significant impact on the investigation of psychopathologies in children and adolescents. This review considers what we can infer from fMRI work regarding the development of conduct disorder (CD) and oppositional defiant disorder (ODD). We make two central assumptions that are grounded in the empirical literature. First, the diagnoses of CD and ODD identify individuals with heterogeneous pathologies; that is, different developmental pathologies can receive a CDD or ODD diagnosis. This is indicated by the comorbidities associated with CD/ODD, some of which appear to be mutually exclusive at the biological level (e.g., posttraumatic stress disorder [PTSD] and psychopathic tendencies). Second, two populations of antisocial individuals can be identified: those that show an increased risk for only reactive aggression and those that show an increased risk for both reactive and instrumental aggression. We review the fMRI data indicating that particular comorbidities of CD/ODD (i.e., mood and anxiety conditions such as childhood bipolar disorder and PTSD) are associated with either increased responsiveness of neural regions implicated in the basic response to threat (e.g., the amygdala) or decreased responsiveness in regions of frontal cortex (e.g., ventromedial frontal cortex) that are implicated in the regulation of the basic threat response. We suggest why such pathology would increase the risk for reactive aggression and, in turn, lead to the association with a CD/ODD diagnosis. We also review the literature on psychopathic tendencies, a condition where the individual is at significantly elevated risk for both reactive and instrumental aggression. We show that in individuals with psychopathic tendencies, the functioning of the amygdala in stimulus-reinforcement learning and of the ventromedial frontal cortex in the representation of reinforcement expectancies is impaired. We suggest why such pathology would increase the risk for reactive and instrumental aggression and thus also lead to the association with a CD/ODD diagnosis.
Excessive activation of ionotropic glutamate receptors increases oxidative stress, contributing to the neuronal death observed following neurological insults such as ischemia and seizures. Posttranslational histone modifications may be key mediators in the detection and repair of damage resulting from oxidative stress, including DNA damage, and may thus affect neuronal survival in the aftermath of insults characterized by excessive glutamate release. In non-neuronal cells, phosphorylation of histone variant H2A.X (termed γ-H2AX) occurs rapidly following DNA doublestrand breaks. We investigated γ-H2AX formation in rat cortical neurons (day in vitro 14) following activation of NMDA or AMPA/Kainate glutamate receptors using fluorescent immunohistochemical techniques. Moreover, we evaluated the co-localization of γ-H2AX "foci" with Mre11, a doublestrand break repair protein, to provide further evidence for the activation of this DNA damage response pathway. Here we show that minimally cytotoxic stimulation of ionotropic glutamate receptors is sufficient to evoke γ-H2AX in neurons and that NMDA-induced γ-H2AX foci formation was attenuated by pretreatment with the antioxidant, Vitamin E, and the intracellular calcium chelator, BAPTA-AM. Moreover, a subset of γ-H2AX foci co-localized with Mre11, indicating that Corresponding Author: Alexei Kondratyev, Ph.D., Assistant Professor, Department of Pediatrics, 3970 Reservoir Rd, NW, The Research Building, W217, Washington, D.C. 20057, Phone: 202-687-0204; Fax: 801-469-5580, e-mail: kondrata@georgetown.edu. We would like to thank Dr. Karen Gale for her valuable feedback and helpful comments in the preparation of this manuscript. We would also like to thank Irina Kats for technical assistance. NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscriptat least a portion of γ-H2AX foci is damage-dependent. The extent of γ-H2AX induction following glutamate receptor activation corresponded to the increases we observed following conventional DNA damaging agents (i.e., non-lethal doses of gamma-radiation (1 Gy) and hydrogen peroxide (10 μM)). These data suggest that insults not necessarily resulting in neuronal death induce the DNA damage-evoked chromatin modification, γ-H2AX, and implicate a role for histone alterations in determining neuronal vulnerability following neurological insults.Keywords histone modification; rat; cortical neurons; gamma-H2AX; glutamate receptorsIn addition to DNA repair protein regulation, post-translational histone modifications can mediate the cellular response to DNA damage (Hassa & Hottiger, 2005). Although the importance of functional DNA-repair pathways is underscored by the abnormal neuronal development and vulnerability to injury observed in DNA repair-deficient mice (Vemuri et al., 2001;Culmsee et al., 2001;Meira et al., 2001;Laposa & Cleaver, 2001) and humans (Rolig & McKinnon, 2000;Brooks, 2002), DNA damage-related histone alterations remain relatively unexamined in neurons.It is well documented in non-neuronal cells ...
The peptide neurotransmitter N-acetylaspartylglutamate is inactivated by extracellular peptidase activity following synaptic release. It is speculated that the enzyme, glutamate carboxypeptidase II (GCPII, EC 3.14.17.21), participates in this inactivation. However, CGCPII knockout mice appear normal in standard neurological tests. We report here the cloning and characterization of a mouse enzyme (tentatively identified as glutamate carboxypeptidase III or GCPIII) that is homologous to an enzyme identified in a human lung carcinoma. The mouse peptidase was cloned from two non-overlapping EST clones and mouse brain cDNA using PCR. The sequence (GenBank, AY243507) is 85% identical to the human carcinoma enzyme and 70% homologous to mouse GCPII. GCPIII sequence analysis suggests that it too is a zinc metallopeptidase. Northern blots revealed message in mouse ovary, testes and lung, but not brain. Mouse cortical and cerebellar neurons in culture expressed GCPIII message in contrast to the glial specific expression of GCPII. Message levels of GCPIII were similar in brains obtained from wild-type mice and mice that are null mutants for GCPII. Chinese hamster ovary (CHO) cells transfected with rat GCPII or mouse GCPIII expressed membrane bound peptidase activity with similar V max and K m values (1.4 lM and 54 pmol/min/mg; 3.5 lM and 71 pmol/min/mg, respectively). Both enzymes are activated by a similar profile of metal ions and their activities are blocked by EDTA. GCPIII message was detected in brain and spinal cord by RT-PCR with highest levels in the cerebellum and hippocampus. These data are consistent with the hypothesis that nervous system cells express at least two differentially distributed homologous enzymes with similar pharmacological properties and affinity for NAAG.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.